Komori
Alfresa Holdings (2784) · FactFirst stated

Higher Revenue and Profit in the FY2018 Q3 Wholesale Business for Prescription Pharmaceuticals and Other Products

First written in FY2018-Q3. . Latest entry: FY2018-Q3.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Revenue and profit growth in the wholesale business for prescription pharmaceuticals and other productsA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2018-Q3First statedAnnual report

    「当第３四半期連結累計期間の業績は、売上高1兆7,389億99百万円(前年同期比1.9％増)、営業利益238億30百万円(同13.0％増)となりました。」

    医療用医薬品等卸売事業は増収増益となった。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Alfresa Holdings yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.